Psychiatric Medication Initiation

Indications for Medication

• Psychiatric medications should be initiated when symptoms are severe enough to impair health-related quality of life, cause persistent distress, or worsen disability, as recommended by the American Heart Association 1, 2
• Medications are strongly recommended for diagnosed depressive disorder, anxiety, post-stroke depression, or pathological affect that interferes with rehabilitation, as suggested by the American Heart Association 2
• Comorbid psychiatric conditions that complicate recovery should be treated with medication, according to the American Heart Association 2

Medication Selection

• SSRIs are often favored due to better side effect profiles, as noted by the American Heart Association and the American Gastroenterological Association 1, 2
• First-line antipsychotic options include haloperidol and second-generation antipsychotics, with monotherapy with an antipsychotic may be effective for initial management, as recommended by the American College of Psychiatry 3
• Lithium and valproate are recommended as first-line mood stabilizer options, with carbamazepine as an alternative, as suggested by the American College of Medicine 3

Treatment Approach

• Routine prophylactic use of antidepressants is not recommended in post-stroke patients, as stated by the American Heart Association 2
• Patients should be given information, advice, and opportunity to talk about the impact of illness on their lives, according to the American Heart Association 2
• Monotherapy with lithium, valproate, or an atypical antipsychotic is recommended as a first-line treatment approach for mood disorders, as suggested by the American Academy of Child and Adolescent Psychiatry 4
• A combination of an antipsychotic with lithium or valproate is recommended for bipolar manic episodes, and an antidepressant with a mood stabilizer for depressive episodes, as suggested by the American College of Psychiatry 3
• Aripiprazole as monotherapy or adjunctive therapy with mood stabilizers is recommended for acute mania/mixed episodes, particularly effective when combined with lithium or valproate 4

Treatment Monitoring and Maintenance

• Antipsychotic treatment should be continued for at least 12 months after remission, and mood stabilizers should be maintained for at least 2 years after the last episode, as recommended by the American College of Medicine 3
• Regular monitoring of lithium levels, renal function, and metabolic parameters is essential, with a high strength of evidence, as recommended by the National Institute of Mental Health [@3@, 5]
• Concentrations of lithium above 1.5 mM can be toxic, and a dose range of 0.6-1.0 mM is considered effective, as suggested by the National Institute of Mental Health 5
• Annual metabolic screening is necessary for patients with bipolar disorder, who have higher rates of metabolic syndrome, obesity, and type 2 diabetes, as stated by the guidelines 4, 6

Psychotherapy and Lifestyle Interventions

• Psychoeducation should be routinely offered to patients and family members, and cognitive-behavioral therapy focused on identifying early warning signs of mood episodes, developing coping strategies for psychotic symptoms, and addressing suicidal thoughts and behaviors is recommended, as suggested by the American Psychiatric Association and the National Institute of Mental Health 7, 3
• Cognitive-behavioral therapy (CBT) and family therapy should be added to the treatment plan, as suggested by the American Psychological Association, the National Institute of Mental Health, and the British Journal of Psychiatry 8, 9, 10
• Regular sleep hygiene to prevent mood destabilization, including consistent sleep-wake schedule and avoidance of sleep deprivation, is crucial, as suggested by the American Psychological Association 7
• Close monitoring for suicidal ideation is essential, especially in patients with a history of multiple suicide attempts, and a safety plan with clear steps for crisis management should be established, as recommended by the American Psychiatric Association 7

Medication Table